Andreia Albuquerque received formal training in research as part of the Harvard Medical School–Portugal Program in Translational Research.
From 2014 to 2017, while she was working as a Gastroenterologist at the Gastroenterology Department of Centro Hospitalar S. João, Porto, Portugal, she started her PhD on anal squamous intraepithelial lesions focusing on biomarkers and epidemiology.
She worked as a researcher and Honorary Consultant at the Homerton Anal Neoplasia Service, Homerton University Hospital in London (2017-2018). She also worked as a Senior Fellow in Inflammatory Bowel Disease (2018-2019), and then, as a Locum IBD Consultant Gastroenterologist (2021-2022) at St. James University Hospital in Leeds, the largest University Hospital in Europe.
In 2019, she completed her PhD at the Faculty of Medicine of the University of Porto. Since then she continued to be active on research on early detection and anal cancer prevention, with several international collaborations.
Currently, she has a total of 86 papers published in peer-review journals, with 59 publications as first author. She has published 24 papers as first author on anal precancerous lesions, in journals as The Lancet Gastroenterology and Hepatology, Journal of Crohn’s and Colitis, The American Journal of Gastroenterology, Clinical Infectious Diseases, British Journal of Cancer and the International Journal of Cancer. She was a member of the 2021 European Crohn’s and Colitis Organization Guidelines on the Management and Prevention of Opportunistic Infections and was part of the International Continence Society Committee on male anorectal dysfunction terminology.
She is an Editorial Board Member of BMC Gastroenterology and of the World Journal of Gastrointestinal Oncology.
She is regularly invited to speak on early detection and prevention of anal cancer. She was a Faculty member at UEG 2023 and has served on the Scientific Organizing Committee for IPVC in 2023, 2024, and 2025, where she also co-chaired several sessions. Between 2023 and 2025, she organized three online webinars for IPVS. In addition, she chaired and organized the first edition of the IPVS Human Papillomavirus-Related Anogenital Diseases Course for Clinicians (IPVS PACC) and led the first edition of the IPVC 2024 High-Resolution Anoscopy Workshop.
She has served as a Board Member of the International Anal Neoplasia Society (IANS) and was a co-chair of the IANS Spanish-Portuguese Task Force. She is currently a Board Member of the International Papillomavirus Society (IPVS), the chair of the IPVS Social Media Committee and a member of the IPVS Education Committee.
